NCT00428090 2017-05-19Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseGlaxoSmithKlinePhase 3 Completed862 enrolled 36 charts
NCT00178841 2016-02-17Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLVanderbilt UniversityPhase 2 Completed4 enrolled 5 charts